Literature DB >> 6480014

Dextropropoxyphene deaths: coroner's report.

R M Whittington.   

Abstract

Dextropropoxyphene has been increasingly prescribed as an analgesic in the UK, chiefly in the form of Distalgesic (dextropropoxyphene hydrochloride 32.5 mg and paracetamol 325 mg per tablet). After reports of sudden deaths from the misuse of this combination, prescribing is declining. Distalgesic remains the most common cause of fatal drug overdose in the West Midlands, UK. The 1983 Birmingham inquests are compared with those from the year 1976 to 1979. In comparison with other drug fatalities, death characteristically occurs rapidly, as little as 1 h after ingestion and usually before hospital treatment can be initiated. Toxicity is increased by alcohol which is also extensively abused. The fatal dose may be as small as 15 tablets or possibly less. Many victims are young and some never intended to take their life. Convulsions and respiratory failure precede death. The elderly and respiratory cripples may be more vulnerable to accidental death. Evidence suggests a liability to dependence or even addiction with dextropropoxyphene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480014     DOI: 10.1177/096032718400300116

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  8 in total

1.  Co-proxamol and suicide: Licence needs to be changed.

Authors:  D N Bateman; R Afshari
Journal:  BMJ       Date:  2003-08-02

2.  Co-proxamol withdrawal has reduced suicide from drugs in Scotland.

Authors:  Euan A Sandilands; D Nicolas Bateman
Journal:  Br J Clin Pharmacol       Date:  2008-04-21       Impact factor: 4.335

3.  Usage of paracetamol-containing combination analgesics remains high in primary care.

Authors:  Cara Usher; Mary Teeling; Kathleen Bennett; Bernie McGowan; John Feely
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

4.  Co-proxamol overdose is associated with a 10-fold excess mortality compared with other paracetamol combination analgesics.

Authors:  R Afshari; A M Good; S R J Maxwell; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

5.  Hazards of codeine plus paracetamol compounds.

Authors:  A S Wylie; A A Fraser
Journal:  Br J Gen Pract       Date:  1994-08       Impact factor: 5.386

6.  A multicentre study of coproxamol poisoning suicides based on coroners' records in England.

Authors:  K Hawton; S Simkin; D Gunnell; L Sutton; O Bennewith; P Turnbull; N Kapur
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

7.  The influence of propoxyphene withdrawal on opioid use in veterans.

Authors:  Corey J Hayes; Teresa J Hudson; Martha M Phillips; Zoran Bursac; James S Williams; Mark A Austin; Mark J Edlund; Bradley C Martin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-08-06       Impact factor: 2.890

8.  Ban on Dextropropoxyphene is Unjustifiable.

Authors:  Savita Butola; Mr Rajagopal
Journal:  Indian J Palliat Care       Date:  2015 Jan-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.